Home > Healthcare > Analytical Instruments > Immunoassay > C-reactive Protein Testing Market

C-reactive Protein Testing Market Trends

  • Report ID: GMI10749
  • Published Date: Aug 2024
  • Report Format: PDF

C-reactive Protein Testing Market Trends

Technological innovations in testing technologies enhancing the accuracy, speed, and convenience of CRP testing, making it a more accessible and reliable tool for diagnosing and monitoring inflammatory conditions, and driving the market growth.
 

  • Recent developments in point-of-care testing (POCT) technology allow for rapid, on-site CRP testing with immediate results. These portable medical devices are especially useful in emergency settings and remote locations, providing quick diagnostic insights without the need for specialized laboratory equipment.
     
  • Additionally, advanced automated analyzers have improved the efficiency and throughput of CRP testing in clinical laboratories. These systems can process multiple samples simultaneously with high precision, reducing turnaround times and minimizing human error.
     
  • Furthermore, innovations in high-sensitivity CRP assays enable the detection of very low levels of CRP, which is crucial for assessing cardiovascular disease risk. Newer hs-CRP tests offer improved sensitivity and specificity, making them valuable for early detection and preventive healthcare.
     
  • Moreover, emerging CRP testing solutions are increasingly being integrated with digital health platforms and electronic health records (EHRs). This integration allows for seamless data management and real-time monitoring, enhancing patient care and facilitating better clinical decision-making. These technological innovations enhance the effectiveness and accessibility of CRP testing, driving market growth globally.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

C-reactive protein testing market size was USD 3.2 billion in 2023 and is expected to register 3.9% CAGR from 2024-2032 owing to the rising prevalence of chronic disorders coupled with an increased demand for CRP testing for the effective diagnosis and management of these conditions worldwide

C-reactive protein testing industry from the kits and reagents segment reached USD 2 billion in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to their versatility and usage with various instruments and platforms, making them suitable for different types of CRP assays.

North America C-reactive protein testing industry recorded USD 1.2 billion in 2023 and is expected to register a commendable CAGR from 2024-2032 due to high prevalence of chronic diseases such as cardiovascular diseases and diabetes in the region.

DxGen Corp, Getein Biotech, Inc., Goldsite diagnostics, HORIBA, Ltd, Laboratory Corporation Of American Holding, LumiraDX, Merck KGaA, Optibio co., Ltd, Randox Laboratories Ltd., and Siemens Healthineers AG, are some of the major C-reactive protein testing companies worldwide.

C-reactive Protein Testing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 18
  • Tables & Figures: 183
  • Countries covered: 23
  • Pages: 130
 Download Free Sample